Skip to main content

Articles

Page 128 of 155

  1. Leflunomide is an immunomodulatory agent used for the treatment of rheumatoid arthritis. In this study, we investigated the effect of A77 1726 – the active metabolite of leflunomide – on the production of IL-1...

    Authors: Gaby Palmer, Danielle Burger, Françoise Mezin, David Magne, Cem Gabay, Jean-Michel Dayer and Pierre-André Guerne
    Citation: Arthritis Res Ther 2004 6:R181
  2. We aimed to assess the effect of ovariectomy on cartilage turnover and degradation, to evaluate whether ovariectomized (OVX) rats could form an experimental model of postmenopausal osteoarthritis. The effect o...

    Authors: Pernille Høegh-Andersen, László B Tankó, Thomas L Andersen, Carina V Lundberg, John A Mo, Anne-Marie Heegaard, Jean-Marie Delaissé and Stephan Christgau
    Citation: Arthritis Res Ther 2004 6:R169
  3. The present studies were initiated to determine the protein expression patterns of fibroblast-like synovial (FLS) cells derived from the synovia of rheumatoid arthritis patients. The cellular proteins were sep...

    Authors: Kumar Dasuri, Mihaela Antonovici, Keding Chen, Ken Wong, Kenneth Standing, Werner Ens, Hani El-Gabalawy and John A Wilkins
    Citation: Arthritis Res Ther 2004 6:R161
  4. Antibodies directed to the Sa antigen are highly specific for rheumatoid arthritis (RA) and can be detected in approximately 40% of RA sera. The antigen, a doublet of protein bands of about 50 kDa, is present ...

    Authors: Erik R Vossenaar, Normand Després, Elvy Lapointe, Annemarie van der Heijden, Maximillian Lora, Tatsuo Senshu, Walther J van Venrooij and Henri A Ménard
    Citation: Arthritis Res Ther 2004 6:R142
  5. Abnormalities in lymphocyte signaling cascades are thought to play an important role in the development of autoimmune disease. However, the large amount of cellular material needed for standard biochemical ass...

    Authors: Amrie C Grammer, Randy Fischer, Olivia Lee, Xuan Zhang and Peter E Lipsky
    Citation: Arthritis Res Ther 2004 6:28
  6. This study was performed to assess the utility of anti-cyclic citrullinated peptide (anti-CCP) antibodies in distinguishing between patients with rheumatoid arthritis (RA) and patients with polyarticular invol...

    Authors: Michele Bombardieri, Cristiano Alessandri, Giancarlo Labbadia, Cristina Iannuccelli, Francesco Carlucci, Valeria Riccieri, Vincenzo Paoletti and Guido Valesini
    Citation: Arthritis Res Ther 2004 6:R137

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.4
    5-year Journal Impact Factor: 4.9
    Source Normalized Impact per Paper (SNIP): 1.294
    SCImago Journal Rank (SJR): 1.518

    Speed 2023
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 111

    Usage 2023
    Downloads: 3,331,819
    Altmetric mentions: 1,885